World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
39031
World Ranking
9958
National Ranking
546

Ernst Holler publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ernst Holler sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 602 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ernst Holler D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ernst Holler sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ernst Holler is affiliated with the University of Regensburg in Germany. The main focus of their research lies within the field of Medicine, with substantial contributions primarily in Hematology, Immunology, Oncology, Molecular Biology, and Genetics. Their scholarly output encompasses 196 publications in Medicine, including 78 in Hematology and 45 in Immunology.

The research topics that Ernst Holler addresses cover a diverse range of specialized areas such as Hematopoietic Stem Cell Transplantation, Immune Cell Function and Interaction, Gut Microbiota and Health, Childhood Cancer Survivors' Quality of Life, Neutropenia and Cancer Infections, T-cell and B-cell Immunology, and Acute Lymphoblastic Leukemia research.

Frequent publication venues for Ernst Holler include:

  • Blood
  • Transplantation and Cellular Therapy
  • Bone Marrow Transplantation
  • Blood Advances
  • Frontiers in Immunology

The scientist's ongoing collaboration network includes working with the following coauthors frequently:

  • Daniel Wolff
  • Wolfgang Herr
  • Daniela Weber
  • Matthias Edinger
  • Hendrik Poeck

Notable recent papers by Ernst Holler feature key topics related to hematopoietic cell transplantation and graft-versus-host disease. These include:

  • "Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation," 2020, New England Journal of Medicine
  • "Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation," 2020, The Lancet Haematology
  • "Acute graft-versus-host disease," 2023, Nature Reviews Disease Primers
  • "The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD," 2020, Blood
  • "National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report," 2021, Transplantation and Cellular Therapy

Best Publications

  • Graft-versus-host disease

    James L M Ferrara;John E Levine;Pavan Reddy;Ernst Holler

  • Donor Leukocyte Transfusions for Treatment of Recurrent Chronic Myelogenous Leukemia in Marrow Transplant Patients

    H.J. Kolb;J. Mittermüller;Ch. Clemm;E. Holler

  • Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

    Jürgen Finke;Wolfgang A Bethge;Claudia Schmoor;Hellmut D Ottinger

  • Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation [see comments]

    E Holler;HJ Kolb;A Moller;J Kempeni

  • Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation

    Jonathan U Peled;Antonio L C Gomes;Sean M Devlin;Eric R Littmann

  • International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.

    Andrew C. Harris;Andrew C. Harris;Rachel Young;Rachel Young;Steven Devine;William J. Hogan

  • Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

    Christoph Schmid;Myriam Labopin;Arnon Nagler;Martin Bornhäuser

  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    Olaf Penack;Monia Marchetti;Tapani Ruutu;Mahmoud Aljurf

  • Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease

    Ernst Holler;Peter Butzhammer;Karin Schmid;Christian Hundsrucker

  • Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

    Nicolaus Kröger;Ernst Holler;Guido Kobbe;Martin Bornhäuser

  • Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy : results of a consensus process by an International Working Group

    Tapani Ruutu;Giovanni Barosi;Richard J. Benjamin;Richard E. Clark

  • Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

    T. Ruutu;A. Gratwohl;T. De Witte;B. Afanasyev

  • Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.

    Gérard Socié;Claudia Schmoor;Wolfgang A. Bethge;Hellmut D. Ottinger

  • Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.

    Justyna Ogonek;Mateja Kralj Juric;Sakhila Ghimire;Pavankumar Reddy Varanasi

  • Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease

    James L.M. Ferrara;Andrew C. Harris;Joel K. Greenson;Thomas M. Braun

  • EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.

    Helene M. Schoemans;Stephanie J. Lee;James L. Ferrara;Daniel Wolff

  • Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)

    E Holler;HJ Kolb;J Mittermuller;M Kaul

  • Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation

    Ernst Holler;Gerhard Rogler;Hans H Herfarth;Julia Brenmoehl

  • Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

    Martin Bornhäuser;Joachim Kienast;Rudolf Trenschel;Andreas Burchert

  • Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease

    Daniel Wolff;Michael Schleuning;Stephanie von Harsdorf;Ulrike Bacher

Frequent Co-Authors

Reinhard Andreesen
Reinhard Andreesen University of Regensburg
Anne M. Dickinson
Anne M. Dickinson Newcastle University
Hans-Jochem Kolb
Hans-Jochem Kolb Ludwig-Maximilians-Universität München
James L.M. Ferrara
James L.M. Ferrara Icahn School of Medicine at Mount Sinai
Matthias Edinger
Matthias Edinger University of Regensburg
Jürgen Finke
Jürgen Finke University of Freiburg
John E. Levine
John E. Levine Icahn School of Medicine at Mount Sinai
Gerhard Rogler
Gerhard Rogler University of Zurich
Hildegard Greinix
Hildegard Greinix Medical University of Graz
Arnold Ganser
Arnold Ganser Hannover Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The field of Medicine in the USA offers a broad spectrum of career pathways beyond becoming a physician. Online education now makes it easier to enter and advance in healthcare careers without traditional barriers. For example, students interested in the administrative side of healthcare may explore a healthcare administration degree to prepare for leadership roles in hospitals and clinics.

Those seeking fast entry into the workforce may benefit from programs such as the medical billing and coding schools with financial aid, which train students for vital roles supporting patient care and may offer accessible tuition options.

For aspiring nurses, there are flexible educational routes like the lpn program without teas test. This allows candidates to begin their nursing careers without standardized exam barriers. Additionally, experienced nurses can accelerate their pathway to advanced practice by enrolling in rn to np programs.

Online healthcare degrees and bridge programs open countless opportunities for career development, making education in medicine more accessible and adaptable than ever.

Best Scientists Citing Ernst Holler

Trending Scientists

Recently Published Articles